These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4916251)

  • 21. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

  • 22. A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis.
    Gyselen A; Verbist L; Cosemans J; Lacquet LM; Prignot J; Simon-Pouthier F; Debrabandere R; Devriendt J
    Acta Tuberc Pneumol Belg; 1969; 60(3):563-76. PubMed ID: 4906105
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term results of treatment with rifampicin in early pulmonary tuberculosis].
    Iodice F
    Arch Monaldi; 1972; 27(1):51-6. PubMed ID: 4568896
    [No Abstract]   [Full Text] [Related]  

  • 24. Five years of clinical experience with rifampicin.
    Gyselen A; Cosemans J; Lacquet LM; Vandenbergh E; Verbist L
    Acta Tuberc Pneumol Belg; 1971; 62(4):289-307. PubMed ID: 4948635
    [No Abstract]   [Full Text] [Related]  

  • 25. A case of probable congenital tuberculosis successfully treated with rifampicin and INH.
    Kotchabhakdi N; Junnanond C
    J Med Assoc Thai; 1978 Aug; 61(8):481-8. PubMed ID: 690536
    [No Abstract]   [Full Text] [Related]  

  • 26. Rifampicin in combination with isoniazid in the treatment childhood tuberculosis.
    Rahaju NN; Sutoto ; Rahaju N; Budiman I; Sutejo
    Paediatr Indones; 1976; 16(11-12):544-53. PubMed ID: 1088375
    [No Abstract]   [Full Text] [Related]  

  • 27. [Investigation on bacteriological relapses in cases of pulmonary tuberculosis treated with INH and RFP--report of the 27th B series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Mochizuki K; Shigeto E; Kobayashi Y; Nagasawa S
    Kekkaku; 1987 May; 62(5):265-80. PubMed ID: 3626256
    [No Abstract]   [Full Text] [Related]  

  • 28. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trial of rifampicin in the treatment of pulmonary tuberculosis in Lagos.
    Makanjuola OO
    Niger Med J; 1973 Jul; 3(3):156-7. PubMed ID: 16366352
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
    Cornudella R; Garcia-Besada JA; Castellano A
    Rev Clin Esp; 1972 Jul; 126(1):59-64. PubMed ID: 5080189
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical results obtained by rifomycin treatment of patients with recent tuberculosis].
    Daddi G; Lucchesi M
    Acta Tuberc Pneumol Belg; 1969; 60(3):521-6. PubMed ID: 5371677
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 35. [Epidemiology of jaundice in phthisiology department: responsibility of rifampicin].
    Oury M; Tuchais E; Tuchais M
    Rev Tuberc Pneumol (Paris); 1970; 34(3):415-22. PubMed ID: 5510436
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacokinetics of rifampicin in patients with pulmonary tuberculosis].
    Gol'dshteĭn VD; Ioffe RA; Kriukov VL
    Probl Tuberk; 1977 Apr; (4):61-6. PubMed ID: 877065
    [No Abstract]   [Full Text] [Related]  

  • 37. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 38. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative bacteriological development in 2 groups of patients with severe pulmonary tuberculosis, 1 treated with a rifampicin-base combination, the other with an INH-base combination].
    Augier J; Parrot R; Marchal G; Gillet P
    Rev Tuberc Pneumol (Paris); 1969; 33(3):414-23. PubMed ID: 5383011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.